DHFB
DXCM icon

Dixon Hubard Feinour & Brown’s DexCom DXCM Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,336
Closed -$2.51M – 193
2021
Q1 		$2.51M Hold
24,336
– – 0.31% 75
2020
Q4 		$2.51M Hold
24,336
– – 0.64% 37
2020
Q3 		$2.51M Buy
24,336
+2,836
+13% +$296K 0.64% 37
2020
Q2 		$2.25M Buy
21,500
+260
+1% +$23.3K 0.58% 40
2020
Q1 		$1.43M Buy
+21,240
New +$1.32M 0.48% 42

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Dixon Hubard Feinour & Brown's DXCM Position: Q2 2021 in Review

Dixon Hubard Feinour & Brown sold out of DexCom (DXCM) in Q2 2021, closing a stake of 24,336 shares — an estimated $2.51M sold.

Dixon Hubard Feinour & Brown first reported a position in DXCM in Q1 2020 and held it in 5 quarters. The position peaked at $2.51M in Q1 2021. 727 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Dixon Hubard Feinour & Brown reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Dixon Hubard Feinour & Brown sold 24,336 DexCom shares in Q2 2021, an estimated $2.51M.
  • Dixon Hubard Feinour & Brown first reported a position in DexCom in Q1 2020 and held it in 5 quarters.
  • Dixon Hubard Feinour & Brown's DexCom position peaked at $2.51M in Q1 2021.
  • 727 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2021, filed 23 Aug 2021.